Expression of a Novel Fusion Recombinant Protein VP8-VP1 in Escherichia coli as a Rota-HAV Vaccine Candidate
-
Published:2023-06-01
Issue:1
Volume:10
Page:34-38
-
ISSN:1727-3706
-
Container-title:Vaccine Research
-
language:en
-
Short-container-title:vacres
Author:
Yarmohammadi Hassan,
Akhavan Sepahi AbbasORCID,
Hamidi-Fard MojtabaORCID,
Aghasadeghi MohammadrezaORCID,
Bahramali GolnazORCID
Publisher
Apex Publishing
Reference38 articles.
1. Brassard J, Seyer K, Houde A, Simard C, Trottier Y-L. Concentration and detection of hepatitis A virus and rotavirus in spring water samples by reverse transcription-PCR. Journal of virological methods. 2005;123(2):163-9.
2. Rigotto C, Victoria M, Moresco V, Kolesnikovas C, Corrêa A, Souza D et al. Assessment of adenovirus, hepatitis A virus and rotavirus presence in environmental samples in Florianopolis, South Brazil. Journal of applied microbiology. 2010;109(6):1979-87.
3. Widdowson M-A, Steele D, Vojdani J, Wecker J, Parashar U. Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines. The Journal of infectious diseases. 2009;200(Supplement_1):S1-S8.
4. Burke RM, Tate JE, Kirkwood CD, Steele AD, Parashar UD. Current and new rotavirus vaccines. Current opinion in infectious diseases. 2019;32(5):435.
5. Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S et al. Risk of intussusception after monovalent rotavirus vaccination. New England Journal of Medicine. 2014;370(6):513-9.